Wonder drug cures cancer Bob Berry
Wonder drug to BEAT cancer: British man ‘cured’ as experts reveal amazing breakthrough
CANCER sufferers were given fresh hope last night after a terminally ill man was “cured” by a new wonder drug.
Bob Berry, 60, underwent the pioneering treatment at Europe’s leading cancer hospital in Manchester. He is one of just 12 patients to be tested with the new treatment globally – three of them in Britain – and is completely free of the disease.
Now scientists hope the revolutionary technique could signal the dawn of a new era in combating cancer. The unnamed drug is said to make cancer more “visible” to the body’s own immune system so follow-up treatment is more effective. It works in conjunction with established treatments which harness and enhance the powers of the immune system to fight cancer.
Yesterday delighted scientists at The Christie in Manchester admitted Mr Berry’s trial went far better than was hoped and paved the way for more clinical success. Dr Matthew Krebs, consultant in experimental cancer medicine at the hospital, said: “Bob’s been taking part in a clinical trial of a new immunotherapy treatment with a brand new drug.
“The idea of this trial is to make the cancer more visible to the immune system.” “He had tablets for a week before the treatment – that does something to the cancer to make it more obvious and visible.” “Then we come on with the immunotherapy that stimulates the immune system to recognise that cancer, so essentially his own body is fighting off the tumour. Bob’s had an absolutely fantastic response.”
Mr Berry, from Stockport, was diagnosed with lung cancer in 2013 but despite surgery, radiotherapy and chemotherapy doctors could not rid him of the disease. He was then given the bombshell news his cancer had spread to his lymph nodes and he had just 18 months to live. So when he was offered the chance to be one of only three Britons to trial the new drug at The Christie he told doctors: “I’ve nothing to lose.”
Bachelor Mr Berry, an ex-engineer, explained: “The people at The Christie referred me to their clinical trials department to try new drugs. I was given only a short time to live, 12 to 18 months, so there wasn’t a lot to lose.
“The only impact is to have given me an extended life. I’m feeling good. I’ve never felt ill all the way.”
“At the end of the day, this clinical trial at The Christie has extended my life and I couldn’t be more grateful.”
The Christie is part of the Manchester Cancer Research Centre working with the University of Manchester and Cancer Research UK to develop anticancer treatments and run trials. Last night Cancer Research UK’s head nurse Martin Ledwick told the Daily Express: “It’s great Bob is doing well and we wish him all the best.”
“Clinical trials are a vital part of research and ensure that cancer patients across the UK get the best treatments.”
Around 600 clinical trials take place at any one time at The Christie’s National Institute of Healthcare Research Clinical Research Facility.
A spokesman for The Christie said: “Bob has admittedly had a phenomenal response to taking part in this clinical trial. His most recent scans show that he’s had a complete response with no apparent trace of tumour in his body.
“We will need to monitor Bob closely and as it is a combined study with a brand new drug, we still have a lot of further research to do before we can establish how these findings can help more patients like Bob in the future.”
A simple blood test that detects pancreatic cancer in its early stages has been developed by scientists. The breakthrough offers hope of a screening programme for one of the deadliest forms of cancer where as many as 80 per cent of cases are identified too late for effective treatment.